Navigation Links
Insmed Completes Sale of Follow-On Biologics Platform to Merck & Co., Inc. for Gross Proceeds of $130 Million
Date:3/31/2009

RICHMOND, Va., March 31 /PRNewswire-FirstCall/ -- Insmed Inc. (Nasdaq: INSM), a biopharmaceutical company, announced today that it has successfully closed the sale of all of the Company's assets related to its follow-on biologics business to a subsidiary of Merck & Co., Inc. As a result of this closing, Insmed has now received $130 million, the aggregate purchase price, for the assets. After fees, taxes and other costs related to the transaction, net proceeds are expected to be approximately $123 million.

As a result of the transaction, Merck purchased all rights to Insmed's follow-on biologic assets, including INS-19 and INS-20, as well as control of the Boulder, Colorado-based manufacturing facility. Merck, through an affiliate, has assumed the facility's lease and ownership of all the equipment in the building. In addition, Merck has offered positions to employees of the Boulder facility. Insmed has retained its Richmond, VA corporate office, which houses its Clinical, Regulatory, Finance, and Administrative functions, in support of the continuing IPLEX(TM) program.

Insmed will continue to carefully evaluate potential uses of the proceeds from the transaction.

RBC Capital Markets served as exclusive financial advisor to Insmed on the transaction and the review of strategic alternatives, and provided a fairness opinion to the Company's Board of Directors. McGuire Woods, LLP acted as legal advisor to Insmed and Fried, Frank, Harris, Shriver & Jacobson LLP acted as legal advisor to Merck.

About Insmed

Insmed Inc. is a biopharmaceutical company with unique protein development experience and a proprietary protein platform aimed at niche markets with unmet medical needs. For more information, please visit http:/
'/>"/>

SOURCE Insmed Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Insmed Announces FDA Issues Statement Regarding Position on Allowing Patients With ALS Access to IPLEX(TM) Under an IND
2. Insmed and Premacure Announce European Orphan Designation for IPLEX(TM) in Retinopathy of Prematurity in Infants
3. Insmed Gains Royalty-Free Worldwide Rights for IPLEX(TM) in Connection with Potential Expanded Access ALS Programs
4. Insmed to Present at Upcoming Healthcare Conferences
5. Insmed to Present at the IBC 5th Annual Global Follow-On Biologics Conference
6. Bioniche Completes Recruitment in First Phase III Clinical Trial with Urocidin(TM)
7. Immunotech Completes Merger Acquisition
8. Arcadia Completes New Financing; Previews Fourth Quarter Results
9. Roche Completes Acquisition of Genentech
10. Phyhealth Completes Funding Transaction with AccessKey IP, Inc.
11. Endo Pharmaceuticals Completes Acquisition of Indevus Pharmaceuticals
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/5/2015)... 2015 After record-breaking sales of ... Walgreens introduces the Cookies & Cream flavor at stores ... Nutrition has continually raised the bar for nutritional snacks. ... with an unprecedented nutritional profile, backed by international patents ... Nutrition will launch additional new products and expand retail ...
(Date:5/5/2015)... 05, 2015 Every year, news articles appear ... out, the worst dry eye season is spring, also known ... most of the United States. The only season offering a ... Sharon Kleyne, host of the Sharon Kleyne Hour™ Power of ... radio show of May 11, 2015. Kleyne is the inventor ...
(Date:5/5/2015)... B. E. Smith, the only full-service leadership solutions ... to recruit a new administrator for Shodair ... firm in the healthcare industry, B. E. Smith has ... , Shodair Children’s Hospital is the only child and ... acute and residential inpatient services, as well as clinical ...
(Date:5/5/2015)... The PracticeMatch Career Fair will take ... at the Rochester Marriott, 1001 First Avenue SW, Rochester, MN ... opportunities will be attending from across the country. All specialties ... raffle prize drawings. , Leslie Thompson, Director of Career Fairs ... to hold a career fair. In the metropolitan area there ...
(Date:5/5/2015)... Atlantic Information Services, Inc. (AIS), ... Health Plans, and other industry-leading health care business ... newsletter, AIS’s Value-Based Care News. Written for health ... companies and their advisers, AIS’s Value-Based Care News ... payments, coordinated care, global payments and other innovative ...
Breaking Medicine News(10 mins):Health News:Nationwide Launch of Extend Nutrition’s Newest Bar Flavors Follows Most Successful New Item Sales in Company History 2Health News:Nationwide Launch of Extend Nutrition’s Newest Bar Flavors Follows Most Successful New Item Sales in Company History 3Health News:Nationwide Launch of Extend Nutrition’s Newest Bar Flavors Follows Most Successful New Item Sales in Company History 4Health News:Nature’s Tears EyeMist tear film supplement soothes dry eye caused by spring pollen season, reports inventor Sharon Kleyne 2Health News:Nature’s Tears EyeMist tear film supplement soothes dry eye caused by spring pollen season, reports inventor Sharon Kleyne 3Health News:Shodair Children’s Hospital Retains B. E. Smith to Recruit New Administrator 2Health News:Shodair Children’s Hospital Retains B. E. Smith to Recruit New Administrator 3Health News:PracticeMatch to Host Physician Career Fair at the Rochester Marriott on May 12, 2015 2Health News:PracticeMatch to Host Physician Career Fair at the Rochester Marriott on May 12, 2015 3Health News:New AIS Newsletter Features Expert Insights and Strategies on Value-Based Care Arrangements 2
... Hydra Booster Concentrated Conditioner Fortifies Water with Naturally Occurring Electromagnetic ... Balance , ... Los Angeles, CA ... a sea of bottled water, sports drinks, energy beverages and ...
... on Children,s Dental Health Available ... - 5 p.m. MDT), SCOTTSDALE, Ariz., July 16 ... Arizona pediatric dentist,( http://www.littlewhitetooth.com/ ) in Scottsdale, and his ... will,be offering a THIRD Free Children,s Dental Day on ...
... Netherlands boost,disability field,s quest to tie in public ... July 16 One of the most complex,issues ... resources and fund,services equitably to people with intellectual ... Supports Intensity Scale (SIS),assessment tool, developed by the ...
... 16 Each year, approximately 200,000,women across the ... menopause when,their ovaries are removed during a hysterectomy. ... are they prepared for what comes next?, ... http://media.medialink.com/WebNR.aspx?story=35350 , Registered journalists can access video, ...
... July 16 Peptimmune, Inc., a privately,held biotechnology ... close,of $8.9 million of its Series D preferred ... Enterprise Associates, MPM Capital, Hunt Ventures,L.P., Boston Medical ... of the Board. The proceeds of the financing ...
... 16, 2008 Anxiety is a normal human response ... a disabling disorder of excessive and irrational fears, such ... Effective treatments are available and can involve either ... sense that combining these two treatments would result in ...
Cached Medicine News:Health News:Hydra Booster Energizes Ordinary Drinking Water for Better Absorption and Optimum Hydration, Stopping Symptoms of 'Hidden' Dehydration 2Health News:Hydra Booster Energizes Ordinary Drinking Water for Better Absorption and Optimum Hydration, Stopping Symptoms of 'Hidden' Dehydration 3Health News:Hydra Booster Energizes Ordinary Drinking Water for Better Absorption and Optimum Hydration, Stopping Symptoms of 'Hidden' Dehydration 4Health News:Hydra Booster Energizes Ordinary Drinking Water for Better Absorption and Optimum Hydration, Stopping Symptoms of 'Hidden' Dehydration 5Health News:THIRD Free Children's Dental Day 2Health News:The Supports Intensity Scale Assessment Can be Used to Build Robust Funding Methods for Developmental Disability Services, New Research Reveals 2Health News:Peptimmune Announces the Second Close of Series D Private Financing 2Health News:D-cycloserine may improve behavioral therapy treatment for anxiety 2
(Date:5/5/2015)... , May 5, 2015  Astellas announced that two ... one abstract detailing clinical data from a study of ... presented during a late breaking plenary session at the ... on May 17 in New Orleans, Louisiana ... Phase 2 studies designed to evaluate enzalutamide compared to ...
(Date:5/5/2015)... MINNEAPOLIS , May 5, 2015 Bio-Techne ... of Directors has decided to pay a dividend of ... 2015. The quarterly dividend will be payable May 29, ... 15, 2015.  Future cash dividends will be considered by ... Bio-Techne Corporation (NASDAQ: TECH ) is a ...
(Date:5/5/2015)... -- - No one has covered cath ... ABMRG - Primary research covering 700 angioplasty ... among states & regions; hospital chains; govt. & pvt. ... coronary stent market in India , ... (BMS) and Bio-Absorbable Stent (BVS), was valued above $400 ...
Breaking Medicine Technology:Astellas Announces New Data To Be Presented During Late Breaking Plenary Session At AUA Annual Meeting 2Astellas Announces New Data To Be Presented During Late Breaking Plenary Session At AUA Annual Meeting 3Astellas Announces New Data To Be Presented During Late Breaking Plenary Session At AUA Annual Meeting 4Astellas Announces New Data To Be Presented During Late Breaking Plenary Session At AUA Annual Meeting 5Astellas Announces New Data To Be Presented During Late Breaking Plenary Session At AUA Annual Meeting 6Astellas Announces New Data To Be Presented During Late Breaking Plenary Session At AUA Annual Meeting 7Astellas Announces New Data To Be Presented During Late Breaking Plenary Session At AUA Annual Meeting 8Astellas Announces New Data To Be Presented During Late Breaking Plenary Session At AUA Annual Meeting 9India Coronary Stent Market to be Tripled by 2021 2India Coronary Stent Market to be Tripled by 2021 3India Coronary Stent Market to be Tripled by 2021 4
... Jazz Pharmaceuticals plc (Nasdaq: JAZZ ) today announced ... on Tuesday, May 8, 2012 at 4:30 p.m. EDT/9:30 p.m. ... and financial update and review first quarter 2012 results. ... from the Investors section of the Jazz Pharmaceuticals website at ...
... IRVINE, Calif., April 30, 2012  PRO-DEX, INC. (Nasdaq: ... in management,s broadcast review of the Company,s fiscal 2012 ... ) The conference call is scheduled ... May 4, 2012 at 4:30 p.m. Eastern Time (1:30 ...
Cached Medicine Technology:Pro-Dex, Inc. Announces Fiscal 2012 Third Quarter Financial Results Conference Call and Webcast 2
The APR Hip System offers a complete line of stems to precisely match patients' anatomic needs and address surgeon preferences....
Classic proven design with superior clinical results....
The Perfecta PDA components provide the design and material choice imperative in today's cost conscious medical climate....
Cementless hip stem revisions offering optimal version setting for each patient. Compatible with modular link ceramic or cobalt chromium femoral heads with up to 4 neck lengths, or the link saddle de...
Medicine Products: